Literature DB >> 34309623

Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.

Matthew S Krantz1, Jason H Kwah2, Cosby A Stone1, Elizabeth J Phillips3,4, Gilbert Ortega5, Aleena Banerji6,7, Kimberly G Blumenthal6,7,8,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34309623      PMCID： PMC8314170          DOI： 10.1001/jamainternmed.2021.3779

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   44.409


× No keyword cloud information.
  36 in total

1.  Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series.

Authors:  Eric Yuk Fai Wan; Yuan Wang; Celine Sze Ling Chui; Anna Hoi Ying Mok; Wanchun Xu; Vincent Ka Chun Yan; Francisco Tsz Tsun Lai; Xue Li; Carlos King Ho Wong; Esther Wai Yin Chan; Kui Kai Lau; Benjamin John Cowling; Ivan Fan Ngai Hung; Ian Chi Kei Wong
Journal:  Lancet Healthy Longev       Date:  2022-07-04

2.  Allergy evaluation of messenger RNA vaccine reactions is crucial, with a specific role for polyethylene glycol testing.

Authors:  Pragya Shrestha; Cosby Allen Stone
Journal:  Ann Allergy Asthma Immunol       Date:  2022-07       Impact factor: 6.248

3.  Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.

Authors:  Vicente Jover Cerdá; Ramón Rodríguez Pacheco; Joan Doménech Witek; Sonia Alonso Hernández; Rafael Durán García; Marina Real Panisello; Francisco Manuel Marco de la Calle
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-27       Impact factor: 3.373

Review 4.  [Anaphylaxis and COVID-19 vaccines].

Authors:  M Castells; P Demoly; L K Tanno
Journal:  Rev Fr Allergol (2009)       Date:  2021-12-30

Review 5.  Adverse Events and Safety of SARS-CoV-2 Vaccines: What's New and What's Next.

Authors:  Kristen B Corey; Grace Koo; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2022-05-10

6.  Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2.

Authors:  Galicia Davila-Fernandez; Gema Vanesa Sanchez-Moreno; Ricardo Madrigal-Burgaleta
Journal:  J Allergy Clin Immunol Pract       Date:  2022-05-03

7.  Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.

Authors:  Eric Macy; Shalin Pandya; Javed Sheikh; Amber Burnette; Jiaxiao M Shi; Joanie Chung; Nancy Gin; William Crawford; Jing Zhang
Journal:  J Allergy Clin Immunol Pract       Date:  2021-12-29

8.  Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines.

Authors:  Matthew Greenhawt; Elissa M Abrams; Marcus Shaker
Journal:  Open Forum Infect Dis       Date:  2021-11-26       Impact factor: 3.835

9.  School Asthma Care During COVID-19: What We Have Learned and What We Are Learning.

Authors:  Elissa M Abrams; Kamyron Jordan; Stanley J Szefler
Journal:  J Allergy Clin Immunol Pract       Date:  2021-11-27

10.  Reactogenicity to COVID-19 vaccination in the United States of America.

Authors:  Adekunle Sanyaolu; Aleksandra Marinkovic; Stephanie Prakash; Priyank Desai; Nafees Haider; Abu Fahad Abbasi; Nasima Mehraban; Isha Jain; Amarachi Ekeh; Omar Shazley; Chuku Okorie; Verner N Orish
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.